Corcept Therapeutics Incorporated (CORT)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 675,040 | 482,375 | 401,858 | 365,978 | 353,874 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $675,040K ÷ $—K
= —
The data provided shows that Corcept Therapeutics Incorporated has not reported any specific values for receivables turnover for the years ending December 31, 2020, 2021, 2022, 2023, and 2024. As receivables turnover ratio is a key indicator of how efficiently a company is managing its receivables, the absence of this data suggests that a detailed analysis of the efficiency of the company in collecting its accounts receivable cannot be performed for the specified years. It is important for a company to regularly monitor and report this ratio to assess its effectiveness in converting its credit sales into cash, and the absence of this information may indicate a lack of transparency or oversight in this aspect of Corcept Therapeutics' financial reporting.
Peer comparison
Dec 31, 2024